MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Levodopa(L-dopa)"

  • 2024 International Congress

    Two unusual cases of dopamine dysregulation syndrome in patients with Parkinson’s disease

    L. Lachance, P. Huot (Montreal, Canada)

    Objective: To present two cases of dopamine dysregulation syndrome (DDS) in patients with Parkinson’s disease (PD) who took extreme measures to access more dopaminergic medication.…
  • 2024 International Congress

    Effect of Levodopa therapy in Hypokinetic Dysarthria in Parkinson’s Disease

    E. Smaoui, N. Farhat, S. Daoud, K. Moalla, N. Bouattour, M. Damak, C. Mhiri (Sfax, Tunisia)

    Objective: The objective of this study was to assess the possible changes in acoustic speech parameters in a cohort of PD patients after acute levodopa…
  • 2024 International Congress

    Analysis of structural connectivity in relation to change in dopaminergic medication after 6 months of STN-DBS in Parkinson´s disease – a pilot study

    š. Janovič, D. Kroneberg, B. Al-Fatly, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To describe the relationship between structural connectivity and it´s effect on change in levodopa equivalent daily dose (LEDD) in patients 6 months after subthalamic…
  • 2024 International Congress

    Changes in Parkinson’s Disease and Parkinsonian Syndromes A Comparative Retrospective Study in Kyrgyzstan

    S. Medetbekova, B. Nurbekova (Bishkek, Kyrgyzstan)

    Objective: This study compares Parkinson's disease (PD) and parkinsonian syndromes (PS) in patients at a Kyrgyzstan university hospital. It analyzes data from 2016-2017 [1] and…
  • 2024 International Congress

    Predictability of Motor States With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease

    R. Hauser, M. Bouchard, D. Santos-Garcia, L. Bergmann, R. Gupta, L. Harmer, M. Shah, C. Yan, S. Isaacson (Tampa, USA)

    Objective: To assess predictability of “On” or “Off” motor states in patients (pts) with advanced Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa (LDp/CDp). Background: Pts with…
  • 2024 International Congress

    Characterizing levodopa-induced dyskinesias using multimodal neuroimaging, clinical and behavioral measures

    S. Shukla, S. Tinaz, N. Thirugnanasambandam (Mumbai, India)

    Objective: Our objective is to investigate potential differential modulation in motor and executive function networks among patients with LID, and to explore its correlation with…
  • 2024 International Congress

    Clinical profile of early-onset Parkinson’s disease

    S. Peña Martinez, R. Ayala Minero, R. Amaya, A. Medina Escobar, P. Salles (San Salvador, El Salvador)

    Objective: Describe motor and non-motor symptoms, complications and treatment in patients with early-onset Parkinson's disease (EOPD) Background: PD usually affecting people over age 60, clinically…
  • 2024 International Congress

    Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson’s Disease

    XD. Yang, Q. Xiao, XQ. He (Shanghai, China)

    Objective: We sought to determine whether fecal bile acids (BAs) could affect levodopa response assessed by levodopa challenge test (LCT) in patients with Parkinson’s disease…
  • 2024 International Congress

    Levodopa response is an inadequate and often biased correlate of STN-DBS outcomes

    J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)

    Objective: To investigate the reliability of the relationship between levodopa response and subthalamic nucleus (STN) DBS outcomes in Parkinson disease (PD). Background: Levodopa response (LR)…
  • 2024 International Congress

    The bypassing and embedded PEG J

    R. Edward, O. Mitchell, W. Han, G. Singh Alg (London, United Kingdom)

    Objective: Our aim is to highlight the improvement on quality of life of using a duodenal levodopa infusion. In addition, we want to emphasize the continuing…
  • 1
  • 2
  • 3
  • …
  • 57
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley